You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR METHAMPHETAMINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


505(b)(2) Clinical Trials for METHAMPHETAMINE HYDROCHLORIDE

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT00829634 ↗ Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation Completed National Institutes of Health (NIH) N/A 2008-10-01 The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
OTC NCT00829634 ↗ Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation Completed San Francisco General Hospital N/A 2008-10-01 The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
OTC NCT00829634 ↗ Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation Completed University of California, San Francisco N/A 2008-10-01 The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
OTC NCT00829634 ↗ Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation Completed California Pacific Medical Center Research Institute N/A 2008-10-01 The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
OTC NCT01736332 ↗ Factors Affecting Methamphetamine and Opiates Drug Testing Completed National Institute on Drug Abuse (NIDA) Phase 1 2012-07-19 Background: - Some legal over-the-counter drugs (such as Vicks VapoInhaler ) and some foods (such as poppy seeds) may cause a positive screening drug test. This might look like someone used illegal drugs (such as methamphetamines or opiates) when they did not. Researchers are studying how the body handles chemicals that may test like illegal drugs and for how long they may be detected in the body. Blood, saliva, and urine samples will be collected. This study may help improve the effectiveness and accuracy of drug tests. Objectives: - To see how the body handles chemicals that may produce positive screening tests and how additional testing can eliminate positive drug tests from over-the-counter drugs and food. Eligibility: - Healthy volunteers between 18 and 65 years of age. Design: - Participants are screened with a physical exam, medical history, laboratory tests, and ECG. - This study involves an overnight stay on a secure research unit and 2 days of tests. - On the first day, participants will take Vicks VapoInhaler (two inhalations in each nostril) every 2 hours from 9 a.m. to 7 p.m. They will also take a drink containing poppy seeds twice (at about 9 a.m. and 5 p.m.). - On the morning of the second day, participants will take the Vicks VapoInhaler just once. They will be discharged around 5 p.m. - On both days, participants will provide blood and saliva samples several times throughout the day. All of their urine will be collected during the 2 study days....
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for METHAMPHETAMINE HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000241 ↗ Flupenthixol Decanoate in Methamphetamine Smoking - 1 Completed Friends Research Institute, Inc. Phase 2 1994-02-01 The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
NCT00000241 ↗ Flupenthixol Decanoate in Methamphetamine Smoking - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1994-02-01 The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
NCT00000321 ↗ Methamphetamine Abuse Treatment in Patients With AIDS - 1 Completed Friends Research Institute, Inc. Phase 4 1996-10-01 The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.
NCT00000321 ↗ Methamphetamine Abuse Treatment in Patients With AIDS - 1 Completed National Institute on Drug Abuse (NIDA) Phase 4 1996-10-01 The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.
NCT00000340 ↗ Pemoline in the Treatment of Stimulant Dependence - 5 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1996-06-01 The purpose of this study is to assess the efficacy of pemoline in treating cocaine and/or methamphetamine dependent adults with comorbid Adult Attention Deficit Hyperactivity Disorder (ADHD).
NCT00033072 ↗ Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1 Unknown status National Institute on Drug Abuse (NIDA) Phase 1 2001-09-01 The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for METHAMPHETAMINE HYDROCHLORIDE

Condition Name

Condition Name for METHAMPHETAMINE HYDROCHLORIDE
Intervention Trials
Methamphetamine Dependence 43
Methamphetamine Abuse 18
Substance Abuse 16
Amphetamine-Related Disorders 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for METHAMPHETAMINE HYDROCHLORIDE
Intervention Trials
Substance-Related Disorders 30
Amphetamine-Related Disorders 20
Disease 8
HIV Infections 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for METHAMPHETAMINE HYDROCHLORIDE

Trials by Country

Trials by Country for METHAMPHETAMINE HYDROCHLORIDE
Location Trials
United States 156
China 5
Canada 5
Malaysia 3
Australia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for METHAMPHETAMINE HYDROCHLORIDE
Location Trials
California 55
Texas 15
Arkansas 9
Utah 8
Illinois 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for METHAMPHETAMINE HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for METHAMPHETAMINE HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 4 18
Phase 3 6
Phase 2/Phase 3 2
[disabled in preview] 93
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for METHAMPHETAMINE HYDROCHLORIDE
Clinical Trial Phase Trials
Completed 78
Unknown status 16
Recruiting 14
[disabled in preview] 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for METHAMPHETAMINE HYDROCHLORIDE

Sponsor Name

Sponsor Name for METHAMPHETAMINE HYDROCHLORIDE
Sponsor Trials
National Institute on Drug Abuse (NIDA) 64
University of California, Los Angeles 22
Baylor College of Medicine 9
[disabled in preview] 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for METHAMPHETAMINE HYDROCHLORIDE
Sponsor Trials
Other 161
NIH 67
Industry 16
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.